Dobutamaine Versus Milrinone in Cardiorenal Syndrome

NCT02644057 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Could not enroll patients

Conditions

Cardiorenal Syndrome

Interventions

DRUG: Milrinone
DRUG: Dobutamine

Sponsor

Maimonides Medical Center